[Skip to content]

You are here:   Home  »  About us  »  Our news  »  Press release centre
-
.

Press Release

press-fs-title
Title
New research shows most women unlikely to benefit from national AAA screening
press-fs-date
Press release date27/07/2018
press-fs-summary
Summary
New research published in The Lancet, which was funded and supported by the National Institute for Health Research (NIHR), has come to important conclusions about screening women for abdominal aortic aneurysms (AAAs).
press-fs-image
press-fs-story
Press release

The NHS introduced ultrasound screening in men aged 65 and over in 2009 to detect and treat the condition – which arises when the main blood vessel swells in the abdomen, and is symptomless until the point of rupture. Since the launch, the programme has been successfully screening and identifying men at risk of an AAA.


Researchers wanted to see if UK women – who are less likely to have AAAs – could also benefit from a similar screening programme.


Co-author Professor Matthew Bown, from the University of Leicester and honorary consultant vascular surgeon at Leicester’s Hospitals, said: “AAA is a serious condition and although it is less common in women we investigated whether extending the screening to women would be beneficial.”


Project leader and Cambridge statistician Professor Simon Thompson said: “In this project we used a sophisticated computer model to find out whether an AAA screening programme for women would be cost-effective.


“This showed that if women were also offered screening, only a very small number would benefit and the cost of such a screening programme would not be a good use of NHS resources.”


But more research is needed to understand this condition in women. Study co-author Janet Powell, Visiting Professor at Imperial College, said: “We need better information on aortic sizes of women at different ages, and whether screening has adverse effects on quality of life.


“A future step would be to see if there are certain groups of women at higher risk of the disease who might benefit from a targeted screening programme.”



ENDS



Notes to Editor:


1. This research was funded by the NIHR Health Technology Assessment (HTA) Programme and supported by the NIHR Cambridge Biomedical Research Centre.


2. The SWAN study team included researchers from the University of Cambridge, Imperial College London, the University of Leicester, the University of Sheffield and Brunel University London.


3. The research is published in The Lancet: http://www.thelancet.com/journals/lancet/article/PIIS0140-6736(18)31222-4/fulltext


4. The SWAN study found that for every 3,900 women invited for AAA screening, 12 new AAAs would be detected preventing one AAA death at a cost to the NHS of £140,000.


5. For more information about the project: http://www.screeningaaawomen.com/


6. For more information about the NHS AAA screening programme: https://www.nhs.uk/conditions/abdominal-aortic-aneurysm-screening/


7. More information is available from Professor Thompson on 07903 184804, Professor Bown on 07939 086582 or Professor Powell on 07811 358116.

Contact information:
Contact information
For further information, please contact:
BRC Communications team
Cambridge Biomedical Research Campus, Hills Road, Cambridge, CB2 0QQ
Tel: 01223 254619
press-fs-release-no
Press release number
6648
press-fs-month
press-fs-attachments